Celiac plexus block combined with 125I seeds for refractory epigastric pain from abdominal malignancies: a retrospective case–control study
- 11 April 2023
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (6) , 2157-2166
Abstract
Purpose To evaluate the clinical efficacy of celiac plexus block (CPB) combined with 125I seeds implantation (ISI) for refractory epigastric pain from abdominal malignancies. Methods The data of 81 patients with refractory epigastric pain [visual analog scale (VAS) score ≥ 4] from abdominal malignancies were collected in this retrospective case–control study. Group A (n = 40) was treated with CPB alone, while Group B (n = 41) underwent CPB combined with ISI. The primary study endpoints were the VAS score, quality of life (QoL), and local tumor control (LTC) rate. The secondary endpoints were complications, progression-free survival (PFS), and overall survival (OS). Results The VAS scores at week 2 (T2), week 4 (T4), week 8 (T8), and week 12 (T12) in both groups were significantly lower compared with the pretreatment values (all P < 0.01). VAS scores in Group B showed a sustained decrease, especially for “mild pain” and “moderate pain,” while the VAS scores in Group A rebounded at T8 and T12 (both P < 0.01). The QoL in Group B improved significantly from T4 until T12, which better than that at T12 in Group A (all P < 0.01). The LTC rates at T8 were 35.0% and 92.7% in Groups A and B, respectively, with a significant difference (P < 0.01). Group B had a slightly lower complication rate and a slightly longer median PFS/OS than group A, but neither was statistically different (P = 0.09 and P = 0.99, respectively). Conclusion CPB combined with ISI performs more sustained pain relief (up to 12 weeks) compared to CPB alone, and ultimately improves the patients’ QoL.Keywords
Funding Information
- the Major science and technology projects of Henan Province in 2022 (221100310100)
This publication has 24 references indexed in Scilit:
- Celiac Plexus Block and NeurolysisGastrointestinal Endoscopy Clinics of North America, 2018
- Celiac Plexus Block and Neurolysis in the Management of Chronic Upper Abdominal PainSeminars in Interventional Radiology, 2017
- Clinical role of guidance by C-arm CT for 125I brachytherapy on pulmonary tumorsLa radiologia medica, 2017
- Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification SystemCardioVascular and Interventional Radiology, 2017
- Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of lifeRadiation Oncology, 2017
- Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinomaHepatology, 2015
- Combined neurolytic block of celiac and superior hypogastric plexuses for incapacitating upper abdominal cancer pain.2014
- Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growthJournal of Experimental & Clinical Cancer Research, 2011
- Effect of Neurolytic Celiac Plexus Block on Pain Relief, Quality of Life, and Survival in Patients With Unresectable Pancreatic CancerJAMA, 2004
- Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of lifeJournal of Pain and Symptom Management, 2003